Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Blair Smith

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Gynecologic Oncology|February 6, 2017
Recurrent low grade serous ovarian cancer in a 20 year old woman: A case from the Ohio State University College of MedicineDavid E Cohn, Floor J Backes, John J Wallbillich, et al.
Gynecologic Oncology|August 14, 2012
Recurrent ovarian cancer: is there a role for re-treatment with bevacizumab after an initial complete response to a bevacizumab-containing regimen?Georgia A McCann, Blair Smith, Floor J Backes, et al.
American Journal of Obstetrics and Gynecology|August 12, 2019
Preoperative predictors of endometrial cancer at time of hysterectomy for endometrial intraepithelial neoplasia or complex atypical hyperplasiaMonica Hagan Vetter, Blair Smith, Jason Benedict, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 4, 2013
Should bevacizumab be continued after progression on bevacizumab in recurrent ovarian cancer?Floor J Backes, Debra L Richardson, Georgia A McCann, et al.
Gynecologic Oncology|February 6, 2019
Conization pathologic features as a predictor of intermediate and high risk features on radical hysterectomy specimens in early stage cervical cancerMegan L Hutchcraft, Blair Smith, Eric M McLaughlin, et al.
Nature Genetics|December 15, 2015
Timing, rates and spectra of human germline mutationRaheleh Rahbari, Arthur Wuster, Sarah J Lindsay, et al.
American Journal of Physiology. Endocrinology and Metabolism|August 14, 2019
Serum miR-204 is an early biomarker of type 1 diabetes-associated pancreatic beta-cell lossGuanlan Xu, Lance A Thielen, Junqin Chen, et al.
Journal of the American College of Surgeons|May 13, 2008
Durable improvements in efficiency, safety, and satisfaction in the operating roomMartin J Heslin, Barbara E Doster, Sandra L Daily, et al.
HPB Surgery : a World Journal of Hepatic, Pancreatic and Biliary Surgery|December 16, 2014
Risk Factors Associated with Reoperation for Bleeding following Liver TransplantationMaxwell A Thompson, David T Redden, Lindsey Glueckert, et al.
Gynecologic Oncology|June 10, 2017
Multi-disciplinary summit on genetics services for women with gynecologic cancers: A Society of Gynecologic Oncology White PaperLeslie M Randall, Bhavana Pothuri, Elizabeth M Swisher, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Gynecologic Oncology|February 6, 2017
Recurrent low grade serous ovarian cancer in a 20 year old woman: A case from the Ohio State University College of MedicineDavid E Cohn, Floor J Backes, John J Wallbillich, et al.
Gynecologic Oncology|August 14, 2012
Recurrent ovarian cancer: is there a role for re-treatment with bevacizumab after an initial complete response to a bevacizumab-containing regimen?Georgia A McCann, Blair Smith, Floor J Backes, et al.
American Journal of Obstetrics and Gynecology|August 12, 2019
Preoperative predictors of endometrial cancer at time of hysterectomy for endometrial intraepithelial neoplasia or complex atypical hyperplasiaMonica Hagan Vetter, Blair Smith, Jason Benedict, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 4, 2013
Should bevacizumab be continued after progression on bevacizumab in recurrent ovarian cancer?Floor J Backes, Debra L Richardson, Georgia A McCann, et al.
Gynecologic Oncology|February 6, 2019
Conization pathologic features as a predictor of intermediate and high risk features on radical hysterectomy specimens in early stage cervical cancerMegan L Hutchcraft, Blair Smith, Eric M McLaughlin, et al.
Nature Genetics|December 15, 2015
Timing, rates and spectra of human germline mutationRaheleh Rahbari, Arthur Wuster, Sarah J Lindsay, et al.
American Journal of Physiology. Endocrinology and Metabolism|August 14, 2019
Serum miR-204 is an early biomarker of type 1 diabetes-associated pancreatic beta-cell lossGuanlan Xu, Lance A Thielen, Junqin Chen, et al.
Journal of the American College of Surgeons|May 13, 2008
Durable improvements in efficiency, safety, and satisfaction in the operating roomMartin J Heslin, Barbara E Doster, Sandra L Daily, et al.
HPB Surgery : a World Journal of Hepatic, Pancreatic and Biliary Surgery|December 16, 2014
Risk Factors Associated with Reoperation for Bleeding following Liver TransplantationMaxwell A Thompson, David T Redden, Lindsey Glueckert, et al.
Gynecologic Oncology|June 10, 2017
Multi-disciplinary summit on genetics services for women with gynecologic cancers: A Society of Gynecologic Oncology White PaperLeslie M Randall, Bhavana Pothuri, Elizabeth M Swisher, et al.
Pageof 4